Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (18 Aug 2025): | 663.80 |
| Day range: | 662.69 / 666.21 |
| Change abs./rel.: | 2.90 / 0.44% |
| Year range: | 544.13 / 711.97 |
| Name | Number of shares |
|---|---|
| MERCK KGAA | 0.10177 |
| NOVO NORDISK A/S | 0.293717 |
| RECORDATI SPA | 0.677898 |
| BAYER AG | 0.591223 |
| ROCHE HOLDING AG | 0.296657 |
| NOVARTIS AG | 0.332123 |
| SANDOZ GROUP AG | 0.45607 |
| GENMAB A/S | 0.409759 |
| ASTRAZENECA PLC | 0.468413 |
| UCB SA | 0.430614 |
| GALDERMA GROUP AG | 0.20249 |
| ARGENX SE | 0.210617 |
| SANOFI SA | 0.335898 |
| GSK PLC | 1.834645 |
| SWEDISH ORPHAN BIOVITRUM AB | 0.632792 |